Related Experiment Video
Updated: Feb 16, 2026

Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction
Published on: July 26, 2018
Arrhythmia-Induced Cardiomyopathy: Prevalent, Under-recognized, Reversible
Rahul Dhawan1, Rakesh Gopinathannair1
1Department of Internal Medicine, University of Louisville, Louisville, KY.
Insights
Arrhythmia-induced cardiomyopathy (AIC) is a heart condition caused by abnormal heart rhythms, potentially leading to heart failure. Early detection and treatment of the arrhythmia can improve heart function and resolve symptoms.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Research
Background:
- Arrhythmia-induced cardiomyopathy (AIC) results from persistent tachyarrhythmia or frequent ectopy, causing ventricular dysfunction and systolic heart failure.
- AIC affects both children and adults, presenting asymptomatically or with overt heart failure.
- Molecular and cellular mechanisms linking tachyarrhythmias to cardiomyopathy are increasingly understood.
Purpose of the Study:
- To review the pathophysiology, clinical presentation, and management of arrhythmia-induced cardiomyopathy.
- To highlight the potential for recovery with arrhythmia treatment.
- To identify areas requiring further research, including predisposing factors and long-term prognosis.
Main Methods:
- Literature review of existing studies on arrhythmia-induced cardiomyopathy.
- Analysis of clinical presentations and outcomes.
- Discussion of molecular and cellular mechanisms.
Main Results:
- AIC can be reversed or improved by treating the underlying arrhythmia.
- Early diagnosis and intervention are crucial for improving cardiac function and preventing heart failure.
- Recurrent arrhythmias can lead to persistent adverse cardiac remodeling.
Conclusions:
- Aggressive treatment of the culprit arrhythmia is key to resolving heart failure in AIC.
- Further research is needed to clarify predisposing factors, diagnostic strategies, and long-term outcomes.
- Understanding AIC is vital for managing patients with heart failure and arrhythmias.
Abstract:
Arrhythmia-induced cardiomyopathy (AIC) is a clinical condition in which a persistent tachyarrhythmia or frequent ectopy contribute to ventricular dysfunction leading to systolic heart failure. AIC can be partially or completely corrected with adequate treatment of the culprit arrhythmia. Several molecular and cellular alterations by which tachyarrhythmias lead to cardiomyopathy have been identified. AIC can affect children and adults, can be clinically silent in the form of asymptomatic tachycardia with cardiomyopathy, or can present with manifest heart failure. A high index of suspicion for AIC and aggressive treatment of the culprit arrhythmia can result in resolution of heart failure symptoms and improvement in cardiac function. Recurrent arrhythmia, following recovery from the index episode, can hasten the left ventricular dysfunction and result in HF, suggesting persistent adverse remodeling despite recovery of left ventricular function. Several aspects of AIC, such as predisposing factors, early diagnosis, preventive measures to avoid adverse remodeling, and long-term prognosis, remain unclear, and need further research.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Mechanism of Cardiac Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy

